Company

Oxygen Biotech

Pharmaceutical Manufacturing United States 4 employees

Employees: 4
Contacts: 1
Emails: 1

oxygenbiotech.com LinkedIn

Oxygen Biotech Overview

Headquarters: United States
Website: oxygenbiotech.com
Industry: Pharmaceutical Manufacturing
Employees: 4
Founded: 2020
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

IT Consulting

About Oxygen Biotech

Oxygen Biotech is developing BAZE-X1, an all-in-one treatment for the patients with severe COVID-19 (SARS-CoV-2) / ARDS & post-COVID Syndrome (PCS). We follow on from the R&D organization BIOCEV — a joint project of six institutes of the Academy of Sciences of the Czech Republic and two faculties of Charles University in Prague (Faculty of Science and 1st Faculty of Medicine). BAZE-X1 is a patented drug that has „dual-mode“ of action: ◼︎ antiviral ◼︎ immunomodulatory Our team consists of leading Czech scientists, clinicians, and internationally recognized specialists both in the European Union (EU) and the United States of America (USA).

Oxygen Biotech Contact Details

People in AeroLeads: 2
With contact data: 1
Email contacts: 1; 50.0% coverage

Oxygen Biotech Org Chart

Sample employees and titles

Name	Title	Location	Contact
Lenka Foslien	Executive Assistant / Project Manager	Prague, Czechia, Czech Republic	Email
Jack Schlereth	Lab General Manager at Oxygen Biotech	Wp. Kuala Lumpur, Federal Territory of Kuala Lumpur, Malaysia	View